Influence of anti-Spike protein antibody levels on tocilizumab efficacy in hospitalized patients with severe COVID-19 pneumonia: a post-hoc analysis of the COVACTA trial

Authors

Ana García‐Casas (ORCID: https://orcid.org/0000-0002-1186-8054)
Carles Forné (ORCID: https://orcid.org/0000-0002-8133-3274)
José Aguareles (ORCID: https://orcid.org/0000-0003-1490-744X)
Javier T Solera (ORCID: https://orcid.org/0000-0001-6833-6625)
Daniel Carnevali-Ruiz
Pablo Guisado‐Vasco (ORCID: https://orcid.org/0000-0003-3019-4398)
Guillermo Santamaría-Corral (ORCID: https://orcid.org/0000-0002-7544-0604)
Gabriel Sotres-Fernández (ORCID: https://orcid.org/0000-0002-7432-5305)

Institutions

Universitat de Lleida (ES)
Hospital Universitario Quirónsalud Madrid (ES)
Universidad Europea de Madrid (ES)

Publication Details

Journal: BMC Infectious Diseases
Published: 2025-05-08
DOI: https://doi.org/10.1186/s12879-025-11001-6
Citations: 1
Primary Topic: COVID-19 Clinical Research Studies
Type: article
Field-Weighted Citation Impact: 1.40

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Influence of anti-Spike protein antibody levels on tocilizumab efficacy in hospitalized patients with severe COVID-19 pneumonia: a post-hoc analysis of the COVACTA trial

Ana García‐Casas, Carles Forné, José Aguareles, Javier T Solera et al.

May 8, 2025

1 citations

BMC Infectious Diseases

COVID-19 Clinical Research Studies

1.40

article

Influence of anti-Spike protein antibody levels on tocilizumab efficacy in hospitalized patients with severe COVID-19 pneumonia: a post-hoc analysis of the COVACTA trial

Ana García‐Casas, Carles Forné, José Aguareles, Javier T Solera, Daniel Carnevali-Ruiz, Pablo Guisado‐Vasco, Guillermo Santamaría-Corral, Gabriel Sotres-Fernández

May 8, 2025article en

1 citations

Abstract

No abstract available for this paper.

BMC Infectious DiseasesVol. 25(1)

Universitat de Lleida (ES), Hospital Universitario Quirónsalud Madrid (ES), Universidad Europea de Madrid (ES)

Good health and well-being

Openalex Percentile: Top 21%

COVID-19 Clinical Research Studies

1.40

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.